Faron Pharmaceuticals - Innovative medical solutions (Part 2)

What bias is this based on? “Researchers affiliated with Faron manage to cram Bex into every article they publish. If an investor starts reading these with 100% intensity, they can easily drift into a kind of confirmation bias.”

The article doesn’t seem to mention Bex, Cleve [Clevegen], or the gene encoding it, STAB1. It doesn’t seem to be in those three exercise/immunology references where Maija has been one of the authors, either. Maija has been involved in designing the research and performing laboratory analyses. She is an immunologist at MediCity in Turku and is involved in Turku’s collaborative networks, and fortunately, she is not regarded as someone who pushes one thing everywhere, so she remains acceptable as a neutral researcher for collaborations.

Bono is raving about the melanoma results. Likewise, Choueiri from Faron’s scientific board.

14 Likes